GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc. (CRVO) | 8/7/2026 4:39:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $25,992,471 | |||
| CervoMed Inc. (CRVO) | 5/18/2026 5:01:44 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $0 | Assets $15,112,918 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 5/15/2026 9:21:51 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $15,112,918 | |||
| CervoMed Inc. (CRVO) | 4/30/2026 10:20:11 AM | View | Proxy | SEC | Y 2025 | ||||||
| CervoMed Inc. (CRVO) | 3/17/2026 5:19:47 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $8,726 -99.6% | Assets $22,879,018 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 3/13/2026 5:15:04 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $4,006,510 -58.9% | Assets $22,879,018 | ||
| CervoMed Inc. (CRVO) | 11/10/2025 4:06:44 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $322,569 -83.4% | Assets $30,610,778 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 11/7/2025 4:56:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $322,569 -83.4% | Assets $30,610,778 | ||
| CervoMed Inc. (CRVO) | 8/11/2025 8:15:52 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,757,724 -46.6% | Assets $38,081,399 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 8/8/2025 9:24:23 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,757,724 -46.6% | Assets $38,081,399 | ||
| CervoMed Inc. (CRVO) | 5/12/2025 4:30:24 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,917,491 -18.3% | Assets $38,577,488 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 5/12/2025 9:12:08 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,917,491 -18.3% | Assets $38,577,488 | ||
| CervoMed Inc. (CRVO) | 4/29/2025 4:48:25 PM | View | Proxy | SEC | Y 2024 | ||||||
| CervoMed Inc. (CRVO) | 3/18/2025 4:09:42 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $2,162,002 -13.2% | Assets $43,081,610 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 3/17/2025 8:26:42 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,737,974 +36.3% | Assets $43,081,610 | ||
| CervoMed Inc. (CRVO) | 11/13/2024 4:02:49 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $1,939,751 +27.1% | Assets $48,883,867 | EPS -$0.55 | Export Earnings Model | |
| CervoMed Inc. (CRVO) | 11/12/2024 9:43:43 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $1,939,751 +27.1% | Assets $48,883,867 | EPS -$0.55 | |
| CervoMed Inc. (CRVO) | 8/15/2024 4:09:13 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $3,288,971 | Assets $53,190,649 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 8/9/2024 4:28:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $3,288,971 | Assets $53,190,649 | ||
| CervoMed Inc. (CRVO) | 5/15/2024 5:07:42 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,347,250 | Assets $7,997,448 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 5/15/2024 8:02:05 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $2,347,250 | Assets $7,997,448 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 5/14/2024 4:18:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,347,250 | Assets $7,997,448 | ||
| CervoMed Inc. (CRVO) | 4/29/2024 4:08:07 PM | View | Proxy | SEC | Y 2023 | ||||||
| CervoMed Inc. (CRVO) | 4/5/2024 4:13:52 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,347,250 | Assets $7,997,448 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 4/1/2024 8:00:53 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $2,347,250 | Assets $7,997,448 | Export Earnings Model | ||
| CervoMed Inc. (CRVO) | 3/29/2024 4:17:06 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $7,144,872 | Assets $9,972,521 | ||
| CervoMed Inc. (CRVO) | 11/13/2023 4:10:51 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $1,526,482 | Assets $12,037,863 | EPS -$0.70 | Export Earnings Model | |
| CervoMed Inc. (CRVO) | 11/13/2023 6:49:52 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $1,526,482 | Assets $12,037,863 | EPS -$0.70 | |
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/8/2023 4:47:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $15,694,618 | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/15/2023 8:31:27 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $18,404,886 | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/24/2023 4:19:17 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $22,635,052 | EPS $2,038,891.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 12/5/2022 5:13:13 PM | View | Proxy | SEC | Y 2021 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/14/2022 4:26:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $26,322,842 | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/14/2022 4:04:19 PM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/16/2022 4:23:26 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/12/2022 6:18:23 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $29,184,025 | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/11/2022 6:50:32 PM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/16/2022 5:07:08 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/12/2022 4:38:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $33,574,129 | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/12/2022 4:08:42 PM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/28/2022 5:26:54 PM | View | Proxy | SEC | Y 2021 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/21/2022 4:28:14 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/21/2022 7:21:22 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/18/2022 4:34:10 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $37,839,151 | EPS $1,946,859.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 2/28/2022 6:17:55 PM | View | Proxy | SEC | Y 2021 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/10/2021 8:13:27 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $40,880,503 | EPS $101,903,979.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/10/2021 8:02:12 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/13/2021 4:32:35 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/11/2021 8:15:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $52,711,062 | EPS $101,903,979.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/12/2021 7:31:04 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/7/2021 4:52:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $56,213,111 | EPS $83,420,184.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/30/2021 4:45:42 PM | View | Proxy | SEC | Y 2020 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/17/2021 4:37:29 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/17/2021 6:12:29 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $27,729,551 | EPS $53,831,973.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/12/2020 5:32:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $31,916,973 | EPS $64,011,342.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/12/2020 4:58:57 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/10/2020 5:01:54 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/7/2020 4:22:27 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $35,993,126 | EPS $51,978,286.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/11/2020 5:14:20 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/11/2020 4:15:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $21,057,126 | EPS $34,507,496.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/29/2020 4:50:29 PM | View | Proxy | SEC | Y 2019 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/18/2020 5:23:04 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/17/2020 4:12:20 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $24,110,523 | EPS $6,706,509.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/12/2019 8:20:17 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/8/2019 4:43:50 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $16,197,214 | EPS $4,693,290.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/8/2019 4:37:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $18,929,138 | EPS $3,940,684.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/9/2019 4:24:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $15,987,819 | EPS $3,376,230.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/9/2019 4:07:37 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/30/2019 4:43:40 PM | View | Proxy | SEC | Y 2018 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/20/2019 9:00:46 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/19/2019 4:10:53 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $18,201,992 | EPS $3,242,301.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/14/2018 4:06:24 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/13/2018 4:22:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $23,594,668 | EPS $3,371,468.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/14/2018 4:31:44 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/10/2018 4:16:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $29,943,836 | EPS $3,369,770.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/10/2018 4:49:08 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/10/2018 4:24:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $33,366,978 | EPS $2,814,316.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/30/2018 3:50:00 PM | View | Proxy | SEC | Y 2017 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/3/2018 12:26:54 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 4/2/2018 4:24:00 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $26,145,815 | EPS -$29.11 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/13/2017 6:44:20 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $28,327,243 | EPS $0.20 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/13/2017 6:35:01 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 9/18/2017 5:05:05 PM | View | Proxy | SEC | Y 2016 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/14/2017 4:35:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $33,906,429 | EPS -$1.00 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/14/2017 4:24:50 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/15/2017 5:12:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $36,343,543 | EPS -$2.78 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/15/2017 4:53:02 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/15/2017 4:29:26 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/12/2017 3:26:36 PM | View | Proxy | SEC | Y 2016 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/31/2017 4:23:41 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/31/2017 11:55:38 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $17,484,384 | EPS -$1.76 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 12/8/2016 4:39:05 PM | View | Proxy | SEC | Y 2015 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/14/2016 2:14:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $19,046,913 | EPS -$0.53 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 11/14/2016 11:29:35 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/15/2016 4:27:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $19,924,477 | EPS -$0.37 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 8/15/2016 4:20:00 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 6/10/2016 7:12:58 AM | View | Proxy | SEC | Y 2015 | ||||||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/16/2016 4:17:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $22,910,977 | EPS -$0.62 | ||
| Diffusion Pharmaceuticals Inc. (CRVO) | 5/16/2016 4:11:04 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| Diffusion Pharmaceuticals Inc. (CRVO) | 3/25/2016 11:06:02 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $2,276,596 | EPS -$2.56 | ||
| RestorGenex Corp (CRVO) | 11/12/2015 4:37:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $23,377,867 | EPS -$0.64 | ||
| RestorGenex Corp (CRVO) | 11/12/2015 4:32:13 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 8/12/2015 4:45:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $36,654,353 | EPS -$0.06 | ||
| RestorGenex Corp (CRVO) | 8/12/2015 4:33:39 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 5/11/2015 4:14:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $39,621,580 | EPS -$0.06 | ||
| RestorGenex Corp (CRVO) | 5/11/2015 4:10:12 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 4/24/2015 7:00:30 AM | View | Proxy | SEC | Y 2014 | ||||||
| RestorGenex Corp (CRVO) | 4/6/2015 7:15:46 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 4/3/2015 4:34:45 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $42,778,751 | EPS -$1.00 | ||
| RestorGenex Corp (CRVO) | 11/12/2014 5:04:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $50,547,258 | EPS -$0.18 | ||
| RestorGenex Corp (CRVO) | 11/12/2014 5:00:40 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 8/14/2014 4:33:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $54,529,269 | EPS -$0.35 | ||
| RestorGenex Corp (CRVO) | 8/14/2014 4:30:54 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,404,886 | Export Earnings Model | |||
| RestorGenex Corp (CRVO) | 5/20/2014 4:50:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $26,447,653 | EPS -$0.23 | ||
| RestorGenex Corp (CRVO) | 4/23/2014 5:16:01 PM | Micro | View | Financials | 10-K/A | SEC | Y 2013 ending: 12/31/2013 | Assets $18,344,052 | EPS -$1.00 | ||
| Stratus Media Group, Inc (CRVO) | 2/12/2014 4:38:36 PM | View | Proxy | SEC | Y 2013 | ||||||
| Stratus Media Group, Inc (CRVO) | 11/19/2013 3:30:38 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $3,235,000 | EPS -$0.37 | ||
| Stratus Media Group, Inc (CRVO) | 8/14/2013 6:12:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $197,000 | EPS $0.82 | ||
| Stratus Media Group, Inc (CRVO) | 7/9/2013 6:21:03 PM | View | Proxy | SEC | Y 2012 | ||||||
| Stratus Media Group, Inc (CRVO) | 5/20/2013 5:12:56 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2013 ending: 3/31/2013 | Assets $2,187,890 | EPS -$2.91 | ||
| Stratus Media Group, Inc (CRVO) | 4/24/2013 4:54:59 PM | Micro | View | Financials | 10-K/A | SEC | Y 2012 ending: 12/31/2012 | Rev: $374,542 -34.3% | Assets $2,446,297 | EPS -$8.16 | |
| Stratus Media Group, Inc (CRVO) | 11/19/2012 2:13:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $143,334 -42.7% | Assets $3,944,125 | EPS -$0.04 | |
| Stratus Media Group, Inc (CRVO) | 10/2/2012 3:53:15 PM | View | Proxy | SEC | Y 2011 | ||||||
| Stratus Media Group, Inc (CRVO) | 9/7/2012 9:40:53 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $143,334 | Assets $3,708,880 | EPS -$0.02 | |
| Stratus Media Group, Inc (CRVO) | 5/21/2012 5:29:32 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $570,476 +1,319.5% | Assets $3,673,552 | EPS -$0.26 | |
| Stratus Media Group, Inc (CRVO) | 11/21/2011 4:37:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $250,201 | Assets $9,080,863 | EPS -$0.06 | |
| Stratus Media Group, Inc (CRVO) | 8/16/2011 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Assets $12,466,915 | EPS -$0.03 |